Analysts Split on Health In Tech as Loss Estimates Widen
Health In Tech, Inc. (NASDAQ: HIT) is drawing renewed scrutiny from Wall Street after Maxim Group issued a fresh round of quarterly earnings estimates that point to continued losses through fiscal
